{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-019844","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.028042+00:00","generated_at":"2026-05-18T06:13:32.799643+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Qualigen granted patents for QN-302 covering 25 countries through 2040","bullets":["Patents for QN-302 granted in over 20 European countries plus India, China, and Russia.","Patent titled 'Substituted Naphthalene Diimides and Their Use' covers product and manufacturing methods.","Expiration extends to 2040; drug targets pancreatic and gastrointestinal cancers.","Qualigen licensed QN-302 from University College of London (Prof. Stephen Neidle).","CEO states patent coverage strengthens position as drug development company."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-019844","json":"https://secwatch.observer/filing/0001641172-25-019844.json","markdown":"https://secwatch.observer/filing/0001641172-25-019844.md","text":"https://secwatch.observer/filing/0001641172-25-019844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225019844/0001641172-25-019844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000164117225019844/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:13:32.799643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}